{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:44Z","timestamp":1761630644248},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/mcg.0b013e31828a37c0","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T14:34:00Z","timestamp":1362666840000},"page":"800-806","source":"Crossref","is-referenced-by-count":1,"title":["A Survey of Hepatitis C Treatment Clinical Practice Patterns Using the Newly Approved Protease Inhibitors"],"prefix":"10.1097","volume":"47","author":[{"given":"Emerson Y.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R13-13-20210305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1365-2893.2001.00310.x","article-title":"Management of hepatitis C patients by primary care physicians in the USA: results of a national survey.","volume":"8","author":"Shehab","year":"2001","journal-title":"J Viral Hepat"},{"key":"R15-13-20210305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJMe1113272","article-title":"A watershed moment in the treatment of hepatitis C.","volume":"366","author":"Chung","year":"2012","journal-title":"N Engl J Med"},{"key":"R18-13-20210305","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1478-3231.2012.02796.x","article-title":"HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians.","volume":"32","author":"Ingiliz","year":"2012","journal-title":"Liver Int"},{"key":"R24-13-20210305","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/hep.24791","article-title":"Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment.","volume":"55","author":"Harrington","year":"2012","journal-title":"Hepatology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCG.0b013e31828a37c0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:11:11Z","timestamp":1620961871000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201310000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":4,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31828a37c0","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}